These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1639230)

  • 61. Pharmacological profile of enantiomerically pure chiral muscarinic agonists: desoxymuscarines.
    De Amici M; Dallanoce C; De Micheli C; Angeli P; Marucci G; Cantalamessa F; Sparapassi L
    Life Sci; 2000 Jun; 67(3):317-26. PubMed ID: 10983875
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative studies of the postjunctional activities of some very potent muscarinic agonists.
    Grana E; Lucchelli A; Zonta F; Santagostino-Barbone MG; D'Agostino G
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):213-8. PubMed ID: 3713868
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
    Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
    Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacological characteristics of indoline derivatives in muscarinic receptor subtypes.
    Adachi S; Koike K; Takayanagi I
    Pharmacology; 1996 Oct; 53(4):250-8. PubMed ID: 8958564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea-pig taenia caeci.
    Gardner AL; Choo LK; Mitchelson F
    Br J Pharmacol; 1988 May; 94(1):199-211. PubMed ID: 2456808
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Central effects of muscarinic agonists and antagonists on hippocampal theta rhythm and blood pressure in the anaesthetised rat.
    Barnes JC; Roberts FF
    Eur J Pharmacol; 1991 Mar; 195(2):233-40. PubMed ID: 1874274
    [TBL] [Abstract][Full Text] [Related]  

  • 67. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mediation by the same muscarinic receptor subtype of phasic and tonic contractile activities in the rat isolated portal vein.
    Pfaffendorf M; Van Zwieten PA
    Br J Pharmacol; 1993 Jan; 108(1):132-8. PubMed ID: 8428203
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine.
    Nakamura T; Sakai A; Isogami I; Noda K; Ueno K; Yano S
    Jpn J Pharmacol; 2002 Feb; 88(2):217-21. PubMed ID: 11928724
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prejunctional effects of muscarinic agonists on 3H-acetylcholine release in the rat urinary bladder strip.
    D'Agostino G; Chiari MC; Grana E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):76-81. PubMed ID: 2797217
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.
    Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ
    Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Muscarinic agonist-mediated heterologous desensitization in isolated ileum requires activation of both muscarinic M2 and M3 receptors.
    Griffin MT; Matsui M; Shehnaz D; Ansari KZ; Taketo MM; Manabe T; Ehlert FJ
    J Pharmacol Exp Ther; 2004 Jan; 308(1):339-49. PubMed ID: 14563784
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pertussis toxin blocks M2 muscarinic receptor-mediated effects on contraction and cyclic AMP in the guinea pig ileum, but not M3-mediated contractions and phosphoinositide hydrolysis.
    Thomas EA; Ehlert FJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1042-50. PubMed ID: 7965766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. New analogues of oxotremorine and oxotremorine-M: estimation of their in vitro affinity and efficacy at muscarinic receptor subtypes.
    Barocelli E; Ballabeni V; Bertoni S; Dallanoce C; De Amici M; De Micheli C; Impicciatore M
    Life Sci; 2000 Jun; 67(6):717-23. PubMed ID: 12659177
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Functional interactions between muscarinic M2 receptors and 5-hydroxytryptamine (5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat.
    Eglen RM; Peelle B; Pulido-Rios MT; Leung E
    Br J Pharmacol; 1996 Oct; 119(3):595-601. PubMed ID: 8894184
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine.
    Giachetti A; Giraldo E; Ladinsky H; Montagna E
    Br J Pharmacol; 1986 Sep; 89(1):83-90. PubMed ID: 2432979
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction.
    Zhou PL; Li YL; Yan LD; Yong Z; Yu G; Dong HJ; Yan H; Su RB; Gong ZH
    World J Gastroenterol; 2013 Mar; 19(9):1444-50. PubMed ID: 23539497
    [TBL] [Abstract][Full Text] [Related]  

  • 80. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.